183 related articles for article (PubMed ID: 36733261)
21. High-intensity focused ultrasound (HIFU) for adenomyosis: Two-year follow-up results.
Shui L; Mao S; Wu Q; Huang G; Wang J; Zhang R; Li K; He J; Zhang L
Ultrason Sonochem; 2015 Nov; 27():677-681. PubMed ID: 26050604
[TBL] [Abstract][Full Text] [Related]
22. Ultrasound-guided HIFU for uterine fibroids of hyperintense on T2-weighted MR imaging with or without GnRH-analogue-pretreated: A propensity score matched cohort study.
Jiang L; Yu JW; Yang MJ; Zhong Q; Chen JY
Front Surg; 2022; 9():975839. PubMed ID: 35990089
[TBL] [Abstract][Full Text] [Related]
23. Non-contrast enhanced MRI for efficiency evaluation of high-intensity focused ultrasound in adenomyosis ablation.
Si M; Lv F; Tang M; Liu Y; Qiu X; Gong C; Hu Y; Liu Y
Int J Hyperthermia; 2024; 41(1):2295813. PubMed ID: 38234000
[TBL] [Abstract][Full Text] [Related]
24. Analysis of related factors influencing postoperative recurrence of adenomyosis treated with HIFU.
Fan LX; Zhang Y; Yang LL; Ji XL; Wang Y; Huang YF; Shi L; Wen Y
Arch Gynecol Obstet; 2024 May; 309(5):1765-1773. PubMed ID: 38347252
[TBL] [Abstract][Full Text] [Related]
25. Gonadotrophin-releasing hormone agonist combined with high-intensity focused ultrasound ablation for adenomyosis: a clinical study.
Guo Y; Duan H; Cheng J; Zhang Y
BJOG; 2017 Aug; 124 Suppl 3():7-11. PubMed ID: 28856862
[TBL] [Abstract][Full Text] [Related]
26. The predictive value of quantitative DCE metrics for immediate therapeutic response of high-intensity focused ultrasound ablation (HIFU) of symptomatic uterine fibroids.
Wei C; Fang X; Wang CB; Chen Y; Xu X; Dong JN
Abdom Radiol (NY); 2018 Aug; 43(8):2169-2175. PubMed ID: 29204677
[TBL] [Abstract][Full Text] [Related]
27. A comparison of reproductive outcomes of patients with adenomyosis and infertility treated with High-Intensity focused ultrasound and laparoscopic excision.
Huang YF; Deng J; Wei XL; Sun X; Xue M; Zhu XG; Deng XL
Int J Hyperthermia; 2020; 37(1):301-307. PubMed ID: 32208771
[No Abstract] [Full Text] [Related]
28. The role of T1 perfusion-based classification in predicting the outcome of magnetic resonance-guided high-intensity focused ultrasound treatment of adenomyosis.
Keserci B; Duc NM
Int J Hyperthermia; 2018 May; 34(3):306-314. PubMed ID: 28540825
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of a radiomics model based on T2-weighted imaging for predicting the efficacy of high intensity focused ultrasound ablation in uterine fibroids.
Cheng Y; Yang L; Wang Y; Kuang L; Pan X; Chen L; Cao X; Xu Y
Quant Imaging Med Surg; 2024 Feb; 14(2):1803-1819. PubMed ID: 38415139
[TBL] [Abstract][Full Text] [Related]
30. Changes in anti-müllerian hormone levels as a biomarker for ovarian reserve after ultrasound-guided high-intensity focused ultrasound treatment of adenomyosis and uterine fibroid.
Lee JS; Hong GY; Lee KH; Kim TE
BJOG; 2017 Aug; 124 Suppl 3():18-22. PubMed ID: 28856867
[TBL] [Abstract][Full Text] [Related]
31. Portable ultrasound-guided high-intensity focused ultrasound with functions for safe and rapid ablation: prospective clinical trial for uterine fibroids-short-term and long-term results.
Lee JY; Chung HH; Kang SY; Park EJ; Park DH; Son K; Han JK
Eur Radiol; 2020 Mar; 30(3):1554-1563. PubMed ID: 31705252
[TBL] [Abstract][Full Text] [Related]
32. The effect of exercise on high-intensity focused ultrasound treatment efficacy in uterine fibroids and adenomyosis: a retrospective study.
Huang X; Yu D; Zou M; Wang L; Xing HR; Wang Z
BJOG; 2017 Aug; 124 Suppl 3():46-52. PubMed ID: 28856860
[TBL] [Abstract][Full Text] [Related]
33. Effect of pre-treatment with gonadotropin-releasing hormone analogue GnRH-α on high-intensity focussed ultrasound ablation for diffuse adenomyosis: a preliminary study.
Xiao-Ying Z; Ying-Shu G; Jiu-Mei C; Jin-Juan W; Hong Y; Chun-Yi Z; Hua D
Int J Hyperthermia; 2018 Dec; 34(8):1289-1297. PubMed ID: 29447020
[TBL] [Abstract][Full Text] [Related]
34. Feasibility of ultrasound-guided high intensity focused ultrasound ablating uterine fibroids with hyperintense on T2-weighted MR imaging.
Zhao WP; Chen JY; Zhang L; Li Q; Qin J; Peng S; Li KQ; Wang ZB; Chen WZ
Eur J Radiol; 2013 Jan; 82(1):e43-9. PubMed ID: 23000188
[TBL] [Abstract][Full Text] [Related]
35. Comparison of pregnancy outcomes in infertile patients with different types of adenomyosis treated with high-intensity focused ultrasound.
Wei J; Wang L; Tao H; Wang X; Zheng F; He P; Zhou L; Fan L; Chen J; Zhong H; Huang W; Zeng D; Li J
Int J Hyperthermia; 2023; 40(1):2238140. PubMed ID: 37495217
[TBL] [Abstract][Full Text] [Related]
36. Microbubble contrast agent SonoVue combined with oxytocin improves the efficiency of high-intensity focused ultrasound ablation for adenomyosis.
Yao R; Zhao W; Gao B; Hu J; Wang T
Int J Hyperthermia; 2021; 38(1):1601-1608. PubMed ID: 34763594
[TBL] [Abstract][Full Text] [Related]
37. The Predictive Effect of Quantitative Analysis of Signal Intensity Heterogeneity on T2-Weighted MR Images for High-intensity Focused Ultrasound Treatment of Uterine Fibroids.
Wang L; Liu Y; Lin J; Pan Y; Liu Y; Lv F
Acad Radiol; 2024 May; ():. PubMed ID: 38704283
[TBL] [Abstract][Full Text] [Related]
38. [Pregnancy outcomes and symptom improvement of patients with adenomyosis treated with high intensity focused ultrasound ablation].
Zhou CY; Xu XJ; He J
Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):845-849. PubMed ID: 27916069
[No Abstract] [Full Text] [Related]
39. Clinical Predictors of Long-term Success in Ultrasound-guided High-intensity Focused Ultrasound Ablation Treatment for Adenomyosis: A Retrospective Study.
Liu X; Wang W; Wang Y; Wang Y; Li Q; Tang J
Medicine (Baltimore); 2016 Jan; 95(3):e2443. PubMed ID: 26817877
[TBL] [Abstract][Full Text] [Related]
40. Safety and Efficacy of Ultrasound-Guided High-Intensity Focused Ultrasound Treatment for Uterine Fibroids and Adenomyosis.
Lee JS; Hong GY; Lee KH; Song JH; Kim TE
Ultrasound Med Biol; 2019 Dec; 45(12):3214-3221. PubMed ID: 31563479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
